Prognostic Implication of CYP2C19 Genotype During Chronic Clopidogrel Monotherapy After Percutaneous Coronary Intervention
JACC: Asia
· Elsevier
Аннотация
Publication date: November 2026 Source: JACC: Asia, Volume 6, Issue 11 Author(s): Jinhwan Jo, Soo-Youn Lee, Ki Hong Choi, Young Bin Song, Byeong-Keuk Kim, Hyung Joon Joo, Kiyuk Chang, Jin-Yong Hwang, Sung Gyun Ahn, Jung-Won Suh, Sang Yeub Lee, Jeehoon Kang, Eun-Seok Shin, Yong Hwan Park, Jong-Young Lee, Jin-Ok Jeong, Chan Joon Kim, Kyeong Ho Yun, Han Cheol Lee, Mahn-Won Park
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Кардиология и сердечно-сосудистая медицина»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
Prognostic Implication of CYP2C19 Genotype During Chronic Clopidogrel Monotherapy After Percutaneous Coronary Intervention. // JACC: Asia. – URL: https://www.sciencedirect.com/science/article/pii/S2772374726008008?dgcid=rss_sd_all
Prognostic Implication of CYP2C19 Genotype During Chronic Clopidogrel Monotherapy After Percutaneous Coronary Intervention. JACC: Asia. https://www.sciencedirect.com/science/article/pii/S2772374726008008?dgcid=rss_sd_all
“Prognostic Implication of CYP2C19 Genotype During Chronic Clopidogrel Monotherapy After Percutaneous Coronary Intervention.” JACC: Asia.
@article{article50443,
title = {Prognostic Implication of CYP2C19 Genotype During Chronic Clopidogrel Monotherapy After Percutaneous Coronary Intervention},
journal = {JACC: Asia},
url = {https://www.sciencedirect.com/science/article/pii/S2772374726008008?dgcid=rss_sd_all}
}